Royal Bank of Canada Reaffirms “Outperform” Rating for HealthEquity (NASDAQ:HQY)

Royal Bank of Canada restated their outperform rating on shares of HealthEquity (NASDAQ:HQY) in a research note released on Wednesday morning, Benzinga reports. They currently have a $92.00 price objective on the stock.

Other equities research analysts also recently issued research reports about the company. Bank of America lowered their price objective on HealthEquity from $105.00 to $100.00 and set a buy rating for the company in a research report on Wednesday. Robert W. Baird lifted their price target on HealthEquity from $98.00 to $104.00 and gave the company an outperform rating in a report on Tuesday, June 4th. Raymond James upped their price objective on shares of HealthEquity from $100.00 to $105.00 and gave the company an outperform rating in a research note on Friday, June 7th. Barrington Research reissued an outperform rating and issued a $105.00 target price on shares of HealthEquity in a research report on Friday, August 30th. Finally, JMP Securities upped their price target on shares of HealthEquity from $101.00 to $105.00 and gave the stock a market outperform rating in a research report on Tuesday, June 4th. One equities research analyst has rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat, HealthEquity currently has an average rating of Moderate Buy and a consensus price target of $103.83.

HealthEquity Stock Down 4.1 %

Shares of NASDAQ HQY opened at $76.24 on Wednesday. The firm’s 50 day moving average price is $77.03 and its 200 day moving average price is $79.67. The company has a debt-to-equity ratio of 0.44, a quick ratio of 4.39 and a current ratio of 4.39. The firm has a market cap of $6.63 billion, a P/E ratio of 82.87, a price-to-earnings-growth ratio of 1.34 and a beta of 0.52. HealthEquity has a 1 year low of $61.81 and a 1 year high of $88.26.

Insider Buying and Selling

In other HealthEquity news, Director Frank Corvino sold 7,705 shares of the firm’s stock in a transaction dated Monday, July 8th. The stock was sold at an average price of $81.89, for a total value of $630,962.45. Following the transaction, the director now directly owns 6,070 shares of the company’s stock, valued at $497,072.30. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In other news, Director Frank Corvino sold 7,705 shares of HealthEquity stock in a transaction that occurred on Monday, July 8th. The shares were sold at an average price of $81.89, for a total transaction of $630,962.45. Following the sale, the director now owns 6,070 shares in the company, valued at $497,072.30. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Vice Chairman Stephen Neeleman sold 35,000 shares of the company’s stock in a transaction on Thursday, July 25th. The shares were sold at an average price of $79.86, for a total transaction of $2,795,100.00. Following the completion of the transaction, the insider now owns 89,769 shares of the company’s stock, valued at $7,168,952.34. The disclosure for this sale can be found here. In the last three months, insiders sold 75,031 shares of company stock valued at $6,103,625. Company insiders own 2.20% of the company’s stock.

Institutional Investors Weigh In On HealthEquity

A number of hedge funds have recently bought and sold shares of HQY. Cape Investment Advisory Inc. purchased a new position in shares of HealthEquity during the 4th quarter valued at approximately $27,000. Rise Advisors LLC acquired a new stake in HealthEquity in the first quarter valued at $28,000. International Assets Investment Management LLC bought a new position in HealthEquity during the 2nd quarter valued at $35,000. YHB Investment Advisors Inc. acquired a new position in HealthEquity during the 1st quarter worth $40,000. Finally, Fidelis Capital Partners LLC bought a new stake in shares of HealthEquity in the 1st quarter worth about $42,000. Institutional investors and hedge funds own 99.55% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.